130 related articles for article (PubMed ID: 38093950)
1. Retracted: S100A8/A9 Molecular Complexes Promote Cancer Migration and Invasion via the p38 MAPK Pathway in Nasopharyngeal Carcinoma.
And Applications BC
Bioinorg Chem Appl; 2023; 2023():9859513. PubMed ID: 38093950
[TBL] [Abstract][Full Text] [Related]
2. S100A8/A9 Molecular Complexes Promote Cancer Migration and Invasion via the p38 MAPK Pathway in Nasopharyngeal Carcinoma.
Xu N; Zhang BB; Huang XN; Yi X; Yan XM; Cai Y; He Q; Han ZJ; Huang YJ; Liu W; Jiao AJ
Bioinorg Chem Appl; 2021; 2021():9913794. PubMed ID: 34257632
[TBL] [Abstract][Full Text] [Related]
3. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
[TBL] [Abstract][Full Text] [Related]
4. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Sunahori K; Yamamura M; Yamana J; Takasugi K; Kawashima M; Yamamoto H; Chazin WJ; Nakatani Y; Yui S; Makino H
Arthritis Res Ther; 2006; 8(3):R69. PubMed ID: 16613612
[TBL] [Abstract][Full Text] [Related]
5. Arterial Thrombosis Is Accompanied by Elevated Mitogen-Activated Protein Kinase (MAPK) and Cyclooxygenase-2 (COX-2) Expression via Toll-Like Receptor 4 (TLR-4) Activation by S100A8/A9.
Chen X; Tao T; Wang H; Zhao H; Lu L; Wu F
Med Sci Monit; 2018 Oct; 24():7673-7681. PubMed ID: 30367682
[TBL] [Abstract][Full Text] [Related]
6. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
[TBL] [Abstract][Full Text] [Related]
7. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
[TBL] [Abstract][Full Text] [Related]
8. Effects of Platycodin D on S100A8/A9-induced inflammatory response in murine mammary carcinoma 4T1 cells.
Ye Y; Pei L; Ding J; Wu C; Sun C; Liu S
Int Immunopharmacol; 2019 Feb; 67():239-247. PubMed ID: 30562685
[TBL] [Abstract][Full Text] [Related]
9. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
10. iPLA2, a novel determinant in Ca2+- and phosphorylation-dependent S100A8/A9 regulated NOX2 activity.
Schenten V; Bréchard S; Plançon S; Melchior C; Frippiat JP; Tschirhart EJ
Biochim Biophys Acta; 2010 Jul; 1803(7):840-7. PubMed ID: 20219570
[TBL] [Abstract][Full Text] [Related]
11. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
Ghavami S; Rashedi I; Dattilo BM; Eshraghi M; Chazin WJ; Hashemi M; Wesselborg S; Kerkhoff C; Los M
J Leukoc Biol; 2008 Jun; 83(6):1484-92. PubMed ID: 18339893
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.
Herik Rodrigo AG; Tomonobu N; Yoneda H; Kinoshita R; Mitsui Y; Sadahira T; Terawaki SI; Gohara Y; Gede Yoni Komalasari NL; Jiang F; Murata H; Yamamoto KI; Futami J; Yamauchi A; Kuribayashi F; Inoue Y; Kondo E; Toyooka S; Nishibori M; Watanabe M; Nasu Y; Sakaguchi M
Biochem Biophys Res Commun; 2022 Dec; 634():83-91. PubMed ID: 36240653
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9.
Schenten V; Melchior C; Steinckwich N; Tschirhart EJ; Bréchard S
J Leukoc Biol; 2011 Apr; 89(4):587-96. PubMed ID: 21233411
[TBL] [Abstract][Full Text] [Related]
14. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
15. Effects of S100 calcium-binding protein A8 (S100A8) and S100 calcium-binding protein A9 (S100A9) on matrix metalloproteinase (MMP) expression in nasopharyngeal carcinoma CNE-2 cells.
Hu W; Tao Z; Zhou Q; Zhao D; Gu L; Zhu S; Chen J
Transl Cancer Res; 2021 Apr; 10(4):1874-1884. PubMed ID: 35116509
[TBL] [Abstract][Full Text] [Related]
16. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
18. The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis.
Bai X; Xu PC; Chen T; Zhang HM; Wu SJ; Yang X; Gao S; Jia JY; Jiang JQ; Yan TK
BMC Immunol; 2022 Sep; 23(1):42. PubMed ID: 36088289
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9812746. PubMed ID: 37387977
[TBL] [Abstract][Full Text] [Related]
20. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells.
Moz S; Basso D; Bozzato D; Galozzi P; Navaglia F; Negm OH; Arrigoni G; Zambon CF; Padoan A; Tighe P; Todd I; Franchin C; Pedrazzoli S; Punzi L; Plebani M
Oncotarget; 2016 Oct; 7(43):69927-69944. PubMed ID: 27655713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
